Novavax, Inc. (NVAX) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.42 --0%
Revenue Growth %: -78.2%
Financial Fact:
Interest income: 554K
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: -78.2%
Financial Fact:
Interest income: 554K
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q4 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.85 million versus the consensus estimate of $6.87 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
- Blue Owl Technology Finance Corp. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Second Quarter Ended June 30, 2026 Financial Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
